CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
CMPI
Delisted
CMPI was delisted on the 27th of May, 2022.
31 hedge funds and large institutions have $64.5M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$338K | |
| 2 | +$145K | |
| 3 | +$115K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$44K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15.1K |
Top Sellers
| 1 | -$803K | |
| 2 | -$241K | |
| 3 | -$149K | |
| 4 |
Renaissance Technologies
New York
|
-$50.5K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$46K |